Pyridoxine-dependent epilepsy
Talk0this wiki
Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Clinical: Approaches · Group therapy · Techniques · Types of problem · Areas of specialism · Taxonomies · Therapeutic issues · Modes of delivery · Model translation project · Personal experiences ·
| Pyridoxine-dependent epilepsy | |
|---|---|
| Classification and external resources | |
| Template:Px Pyridoxine | |
| OMIM | 266100 |
| eMedicine | article/985667 |
Pyridoxine-dependent epilepsy (PDE, EPD) or pyridoxine-dependent seizure (PDS) is an extremely rare disorder characterised by intractable seizures in newborn children that require lifelong B6 supplementation to treat. The disorder was first recognized in the 1950s, with the first description provided by Hunt et al. in 1954. The most likely cause is a mutation in ALDH7A1 (antiquitin) gene.
See also
Edit
External linksEdit
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |
